Huibang Biological is engaging in R&D, production and sales of medicines for the treatment of human diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 24, 2021 | Series B | — | 1 |
|
— | Detail |
Aug 23, 2018 | Angel | ¥3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
Yes | Series B |
|
— | Angel |